比较35-37周妊娠期眼动脉多普勒与PlGF及sFlt-1/PlGF比值对即将发生子痫前期的预测
这项前瞻性观察研究纳入2338例妊娠女性,在35+0至36+6周评估血清PlGF、sFlt-1/PlGF比值及基于母体危险因素、MAP和眼动脉PSV比值的竞争风险模型。在10%假阳性率下,竞争风险模型对3周内子痫前期预测的检出率(96.7%)高于sFlt-1/PlGF比值(70.0%),提示眼动脉多普勒联合母体危险因素和血压可能替代PlGF及sFlt-1/PlGF比值检测。
要点
- 竞争风险模型(母体危险因素+MAP MoM+PSV比值delta)对3周内子痫前期检出率96.7%,优于sFlt-1/PlGF比值70.0%。
- sFlt-1/PlGF比值对3周内子痫前期检出率70.0%,优于PlGF 50.0%和PSV比值56.7%。
- 竞争风险模型对评估后任何阶段子痫前期检出率78.7%,优于sFlt-1/PlGF比值62.7%。
核心结论
- 眼动脉多普勒联合母体危险因素和血压可能替代PlGF及sFlt-1/PlGF比值检测来预测即将发生的子痫前期。
研究设计与样本
- 前瞻性观察研究,纳入2338例妊娠女性,在35+0至36+6周进行常规医院访视,包括母体人口学特征和病史记录、胎儿解剖和生长超声检查、母体眼动脉血流速度波形评估、MAP测量以及血清PlGF和sFlt-1测量。
诊断标准与关键数值
- 在10%假阳性率下,sFlt-1/PlGF比值对3周内子痫前期预测的检出率为70.0%(95%CI 50.6-85.3%),优于PlGF的50.0%(95%CI 31.3-68.7%)和PSV比值的56.7%(95%CI 37.4-74.5%),但低于母体危险因素、MAP MoM和PSV比值delta组合的96.7%(95%CI 82.8-99.9%)。
- 在10%假阳性率下,sFlt-1/PlGF比值对评估后任何阶段子痫前期预测的检出率为62.7%(95%CI 50.7-73.6%),优于PlGF的52.0%(95%CI 40.2-63.7%)和PSV比值的41.3%(95%CI 30.1-53.3%),但低于母体危险因素、MAP MoM和PSV比值delta组合的78.7%(95%CI 67.7-87.3%)。
- 在10%假阳性率下,检出率的经验结果与模型结果一致,无论是3周内子痫前期还是评估后任何阶段子痫前期。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the predictive performance for delivery with pre-eclampsia (PE) at < 3 weeks and at any stage after assessment at 35 + 0 to 36 + 6 weeks' gestation of serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1)/PlGF ratio with that of a competing-risks model utilizing maternal risk factors, mean arterial pressure (MAP) and ophthalmic artery peak systolic velocity (PSV) ratio.
METHODS: This was a prospective observational study of women attending for a routine hospital visit at 35 + 0 to 36 + 6 weeks' gestation. This visit included recording of maternal demographic characteristics and medical history, ultrasound examination of fetal anatomy and growth, assessment of flow velocity waveforms from the maternal ophthalmic arteries and measurement of MAP, serum PlGF and serum sFlt-1. The performance of screening for delivery with PE at < 3 weeks and at any time after the examination was assessed using areas under the receiver-operating-characteristics curves and detection rates (DRs), at a 10% false-positive rate (FPR). McNemar's test was used to compare DRs, at a 10% FPR, between screening by PlGF concentration, the sFlt-1/PlGF concentration ratio and the competing-risks model utilizing maternal risk factors, MAP and ophthalmic artery PSV ratio. Model-based estimates of screening performance for different methods of screening were also produced.
RESULTS: The study population of 2338 pregnancies contained 75 (3.2%) cases that developed PE, including 30 (1.3%) that delivered with PE at < 3 weeks from assessment, and 2263 cases unaffected by PE. The DR of PE at < 3 weeks from assessment, at a 10% FPR, of sFlt-1/PlGF ratio (70.0% (95% CI, 50.6-85.3%)) was superior to that of PlGF (50.0% (95% CI, 31.3-68.7%)) or PSV ratio (56.7% (95% CI, 37.4-74.5%)) but inferior to that of the combination of maternal risk factors, MAP multiples of the median (MoM) and PSV ratio delta (96.7% (95% CI, 82.8-99.9%)). Similarly, the DR of PE at any stage after assessment of sFlt-1/PlGF ratio (62.7% (95% CI, 50.7-73.6%)) was superior to that of PlGF (52.0% (95% CI, 40.2-63.7%)) or PSV ratio (41.3% (95% CI, 30.1-53.3%)) but inferior to that of the combination of maternal risk factors, MAP MoM and PSV ratio delta (78.7% (95% CI, 67.7-87.3%)). The empirical results for DR at a 10% FPR were consistent with the modeled results, both for delivery with PE at < 3 weeks and at any time after assessment.
CONCLUSION: Ophthalmic artery Doppler in combination with maternal risk factors and blood pressure could potentially replace measurement of PlGF and sFlt-1/PlGF ratio in the prediction of imminent PE. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Lau, Wright, Sarno, et al. Comparison of ophthalmic artery Doppler with PlGF and sFlt-1/PlGF ratio at 35-37 weeks' gestation in prediction of imminent pre-eclampsia. Ultrasound Obstet Gynecol. 2022. PMID: 35132725. doi:10.1002/uog.24874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。